BioMatrix Infusion Pharmacy · 9 hours ago
Per Diem Pharmacist
Overland Park, Kansas, United States
Full-time
Onsite
Entry, Mid Level
1+ years expBioMatrix is a nationwide, independently-owned infusion pharmacy with decades of experience supporting patients on specialty medication. The Per Diem Pharmacist is responsible for ensuring quality patient services and safe pharmacy operations in the absence of the pharmacist in charge.
Health CarePharmaceutical
Responsibilities
Directly monitors the pharmacy technicians to assure the quality of patient services and a safe and effective pharmacy operation
Provides safe, appropriate, cost effective, evidence-based medication therapies to patients according to established BioMatrix policies and procedures, and FDA mandates and manufacturer self-imposed restrictions
Completes the prescription order review and verification process, including the match of the dispensing drug to the order and choice of appropriate patient educational medication materials
Conducts initial and disease-specific phone assessments with new patients and refill assessments with existing patients
Maintains a working knowledge of the Ohio State Board of Pharmacy Board rules and regulations (and other states), and the URAC, The Joint Commission, and ACHC Pharmacy Standards
Qualification
Required
Graduate with a BS or Doctorate of Pharmacy from an ACPE-accredited School of Pharmacy required
Current, unrestricted license to practice pharmacy in the state noted in posting required
Experience providing customer service to internal and external customers, including meeting quality standards for services, and evaluation of customer satisfaction
Basic level skill in Microsoft Office (including Word, Excel, PowerPoint, etc)
Preferred
Minimum of 1-2 years in a retail / hospital pharmacy preferred
Company
BioMatrix Infusion Pharmacy
BioMatrix Infusion Pharmacy is a nationwide, independently-owned infusion pharmacy with decades of experience supporting patients on specialty medication.
201-500 employees
Funding
Current Stage
Growth StageTotal Funding
$80M2024-06-25Acquired
2016-12-02Private Equity· $80M
Leadership Team
Kathee Kramm
President and COO
Recent News
Company data provided by crunchbase